Reglan (metoclopramide) is not necessarily stronger than Zofran (ondansetron), but it works differently and hits the problem from more angles. Reglan blocks dopamine receptors in the brain and also affects serotonin and histamine pathways, while Zofran targets only serotonin receptors. That broader mechanism makes Reglan more versatile for certain conditions, but it also comes with more serious risks. Which one works better depends entirely on what’s causing your nausea.
How They Work Differently
Reglan’s primary action is blocking dopamine receptors in the brain’s nausea center, though it also has some effect on serotonin receptors. On top of suppressing nausea signals, Reglan physically speeds up digestion by increasing muscle contractions in the upper digestive tract and tightening the valve between the esophagus and stomach. This makes it genuinely useful for conditions where slow stomach emptying is part of the problem, like gastroparesis or acid reflux.
Zofran takes a more targeted approach. It selectively blocks serotonin receptors in both the gut and the brain’s vomiting center. Serotonin is the main chemical trigger for nausea caused by chemotherapy, surgery, and many infections, which is why Zofran was originally developed for cancer patients. Its narrow focus means fewer side effects but also a narrower range of situations where it excels.
When Reglan Has the Edge
Reglan is the better choice when nausea stems from a sluggish digestive system. If your stomach isn’t emptying properly, as in diabetic gastroparesis, Zofran can quiet the nausea signal in your brain but won’t address the underlying problem. Reglan does both: it reduces nausea and physically moves food through your system. The typical dose for gastroparesis is 10 mg taken four times daily, up to a maximum of 40 mg per day.
Reglan also tends to perform well for migraine-associated nausea. During a migraine, the stomach essentially stalls, which is one reason oral painkillers often don’t work well mid-attack. Reglan can restore normal stomach motility while also calming nausea through its dopamine-blocking action, helping other medications absorb more effectively. This dual benefit gives it a practical advantage that Zofran can’t match in that specific scenario.
When Zofran Has the Edge
For chemotherapy-induced nausea, post-surgical nausea, and stomach bugs, Zofran is generally the first-line choice. It directly blocks the serotonin surge that triggers vomiting in these situations, and it does so with a cleaner side effect profile. Most people tolerate Zofran well, with constipation and headache being the most common complaints.
Zofran also comes in an orally disintegrating tablet that dissolves on the tongue, which is a real advantage when you’re actively vomiting and can’t keep a pill down.
Side Effects Are the Real Differentiator
This is where the comparison gets important. Reglan carries an FDA black box warning for tardive dyskinesia, a movement disorder involving involuntary, repetitive motions of the face and body that can be permanent. The risk increases with longer use and higher total doses, which is why treatment beyond 12 weeks is discouraged in almost all cases. Elderly patients, women, and people with diabetes face higher risk, though there’s no reliable way to predict who will develop it. Other common side effects include drowsiness and restlessness, and some people experience involuntary muscle spasms, especially at higher doses.
Zofran’s most notable risk involves heart rhythm. At higher intravenous doses, it can prolong the QT interval, a measure of electrical activity in the heart that, when stretched, can trigger dangerous arrhythmias. At a standard 8 mg IV dose, the effect on heart rhythm is small (about 5.8 milliseconds) and generally considered low risk. This is mainly a concern for people who already have heart rhythm disorders, low potassium or magnesium levels, or who take other medications that affect heart rhythm. For most people taking oral Zofran at standard doses, this isn’t a practical worry.
Pregnancy Nausea: A Close Call
Both drugs are used for severe pregnancy nausea (hyperemesis gravidarum), and a systematic review of randomized controlled trials found no significant difference in how well they control symptoms. Nausea scores, hospital stay length, and the number of doses needed were essentially equivalent between the two.
The safety profiles differ in meaningful ways, though. A large meta-analysis of over 33,000 patients found no increased risk of major birth defects with Reglan. However, Reglan caused significantly more drowsiness (30% vs. 12.5%) and dry mouth (23.8% vs. 10%) compared to Zofran. Zofran, on the other hand, has been linked to a small increased risk of cleft palate and certain heart defects when used during the first trimester, though the absolute risk remains low. For this reason, Zofran is generally considered safer after the first trimester, while Reglan is typically reserved for cases that don’t respond to other treatments. American College of Obstetricians and Gynecologists guidelines recommend Reglan only in refractory cases, at 5 to 10 mg every 6 to 8 hours.
Choosing Between Them
Neither drug is categorically “stronger.” They target different chemical pathways and shine in different clinical situations. Reglan is the more powerful option when you need both nausea relief and improved stomach motility, but its side effect profile limits how long and how liberally it can be used. Zofran is more targeted, better tolerated, and preferred for serotonin-driven nausea like that caused by chemotherapy or stomach viruses.
If you’ve tried one and it didn’t help, that’s useful information. Because they work through different mechanisms, switching from one to the other can sometimes succeed where the first drug failed. In some clinical settings, the two are even used together for nausea that’s difficult to control, since their non-overlapping mechanisms can complement each other.